RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life ...

IQVIA hopes to help clinical trial sites rein in the number of different software systems they have to manage with a new platform that puts them all behind a single dashboard, potentially improving ...

IQVIA Holdings Inc. IQV yesterday announced the development of Software as a Service (SaaS) safety platform. It is aimed at lowering cost and complexity of pharmacovigilance and enhancing organization ...

What Happened? Shares of clinical research company IQVIA (NYSE: IQV) fell 2.5% in the afternoon session after TD Cowen ...

The number of consumer digital health apps ballooned last year, with more than 90,000 new ones introduced in 2020, according to a new report by the IQVIA Institute for Human Data Science on digital ...

The Federal Trade Commission (FTC) is taking a deeper look into IQVIA’s attempt to snap up Propel Media, which owns pharma digital ad specialist DeepIntent, as the regulator questions whether the deal ...

The Federal Trade Commission's (FTC's) concerns regarding a significant pharma ad deal between IQVIA, the leading biopharma data provider, and Propel Media, the owner of pharma digital ad specialist ...

Companies and institutions continue to conduct clinical trials, indicating that the CRO market demand will continue to grow. The revenues of the TAS segment increased by 7.67% in the first half of ...

For years, the health data company IQVIA has quietly purchased detailed financial and demographic information on tens of millions of Americans from the credit reporting company Experian — one of many ...

Ron Bruehlman to become Senior Advisor to CEO; Michael Fedock Named as New CFO IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and ...